The DART Study: A phase 2 randomized double-blind study of dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma (RCC) Meeting Abstract
| Authors: | Voss, M. H.; Plimack, E.; Rini, B.; Bhatt, R. S.; Alter, R.; Beck, J. T.; Mutyaba, M.; Pappas, K.; Wilson, D.; Zhang, X.; Sun, J.; Glasser, C.; Sherman, M. L.; Pandya, S. S.; Atkins, M. B. |
| Abstract Title: | The DART Study: A phase 2 randomized double-blind study of dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma (RCC) |
| Meeting Title: | 14th International Kidney Cancer Symposium (IKCS) |
| Journal Title: | BJU International |
| Volume: | 116 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2015 Nov 6-7 |
| Meeting Location: | Miami, FL |
| ISSN: | 1464-4096 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2015-12-01 |
| Start Page: | 22 |
| End Page: | 23 |
| Language: | English |
| ACCESSION: | WOS:000366284900045 |
| PROVIDER: | wos |
| PUBMED: | 26492557 |
| DOI: | 10.1111/bju.13365 |
| Notes: | Meeting Abstract -- 14th International Kidney Cancer Symposium -- NOV 06-07, 2015 -- Miami, FL -- SI -- Source: Wos |
